| Net Cash Provided by (Used in) Operating Activities |
$277,886,000 |
USD |
4.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$45,677,000 |
USD |
-104% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,035,470,000 |
USD |
-8.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
170,463,795 |
shares |
0.34% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,802,458,000 |
USD |
-346% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,694,194,000 |
USD |
-3.4% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$434,683,000 |
USD |
-28% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$601,410,000 |
USD |
-1.2% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$83,998,000 |
USD |
-7% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,323,779,000 |
USD |
-15% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$22,453,000 |
USD |
-225% |
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$4,670,000 |
USD |
291% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$2,096,227,000 |
USD |
3.9% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$49,440,000 |
USD |
-4.3% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$1,746,181,000 |
USD |
116% |
Q2 2024 |
Q2 2024 |